Ads
related to: keytruda cancer drug- BENDEKA® Therapy
Learn About An Infusion Therapy
Therapy Plan For Your Patients.
- Dosing & Administration
Get More Information On BENDEKA®
Approved Indications.
- About BENDEKA®
Get Information About BENDEKA®
For Your Patients & Practice.
- BENDEKA® Treatment
Find Important Information
On BENDEKA® Treatment Options.
- Codes & Reimbursement
Find BENDEKA® Billing Codes.
Learn About Patient Reimbursement.
- Support For Patients
Learn About BENDEKA®
Patient Assistance Program.
- BENDEKA® Therapy
Search results
Transcenta’s Osemitamab succeeds in Phase IIa G/GEJ cancer triple combo trial
Clinical Trials Arena via Yahoo Finance· 2 hours agoOsemitamab...cells through antibody-dependent cellular cytotoxicity (ADCC). G/GEJ cancer landscape...
TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment
Clinical Trials Arena via Yahoo Finance· 2 hours agoTILT-123 is an oncolytic adenovirus featuring tumour necrosis factor alpha (TNFα) and interleukin-2...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 1 day agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 7 days agoOne of the drugs, the lung cancer treatment Tagrisso, has already exceeded $5 billion in annual...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 5 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Why Top 4% Biotech Stock, Merus, Just Catapulted To A Record High
Investor's Business Daily· 4 days agoMerus stock catapulted to a record high Friday after its experimental regimen for head-and-neck ...
Immunotherapy for stomach cancer: Types and effectiveness
Medical News Today· 5 days agoImmunotherapy may help shrink a tumor or slow the growth of cancer cells. People may have it in...
Merus (MRUS) Surges 36% on Head & Neck Cancer Antibody Data
Zacks· 1 day agoData from an earlier cut-off date shows that treatment with Merus' (MRUS) combination therapy achieved a 60% response rate in patients with head and neck cancer.
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 4 days agoKeytruda (pembrolizumab) is Merck & Co Inc’s (NYSE:MRK) top selling cancer drug. The abstract...
Hedge Funds Are Loading Up On This Dividend Stock
Benzinga via Yahoo Finance· 20 hours agoThe markets are adjusting to the high interest rates environment, with all the major US stock indices reporting strong gains in May 2024. However, even...
Ad
related to: keytruda cancer drug
